GI
RPRX icon

GAMMA Investing’s Royalty Pharma RPRX Stock Holding History

GAMMA Investing’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$314K Buy
5,595
+789
+16% +$41.1K 0.01% 943
2026
Q1 		$231K Buy
4,806
+618
+15% +$27.1K 0.01% 1013
2025
Q4 		$162K Buy
4,188
+882
+27% +$33.6K 0.01% 1190
2025
Q3 		$117K Buy
3,306
+289
+10% +$10.5K 0.01% 1386
2025
Q2 		$109K Buy
3,017
+440
+17% +$14.6K 0.01% 1380
2025
Q1 		$80.2K Buy
2,577
+106
+4% +$3.36K 0.01% 1440
2024
Q4 		$63K Buy
2,471
+590
+31% +$15.6K 0.01% 1476
2024
Q3 		$53.2K Buy
1,881
+256
+16% +$7.09K 0.01% 1452
2024
Q2 		$42.9K Sell
1,625
-13
-0.8% -$360 0.01% 1309
2024
Q1 		$49.7K Buy
1,638
+1,037
+173% +$30.6K 0.01% 1052
2023
Q4 		$17.1K Buy
+601
New +$16.5K ﹤0.01% 1607

Other funds holding RPRX

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
EB
Eastern Bank Boston, Massachusetts $6.53B AUM 30.05% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
AIM
Achmea Investment Management Zeist, Netherlands $4B AUM 31.99% 1-Year Est. Return
RRAM
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return
KMC
Kirr Marbach & Co Columbus, Indiana $594M AUM 34% 1-Year Est. Return
FVWA
Foster Victor Wealth Advisors Greenville, South Carolina $1.9B AUM 24.46% 1-Year Est. Return
SMDAM
Sumitomo Mitsui DS Asset Management Tokyo, Japan $14.5B AUM 37.68% 1-Year Est. Return

GAMMA Investing's RPRX Position: Q2 2026 in Review

GAMMA Investing increased its Royalty Pharma (RPRX) stake by 16% in Q2 2026, buying an estimated $41.1K and bringing the position to 5,595 shares worth $314K. The position accounts for 0.01% of the portfolio, ranked #943.

GAMMA Investing first reported a position in RPRX in Q4 2023 and has held it in 11 quarters since. 76 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • GAMMA Investing held 5,595 shares of Royalty Pharma worth $314K as of Q2 2026.
  • GAMMA Investing bought 789 Royalty Pharma shares in Q2 2026, an estimated $41.1K.
  • Royalty Pharma made up 0.01% of GAMMA Investing's portfolio in Q2 2026, its #943 holding.
  • GAMMA Investing first reported a position in Royalty Pharma in Q4 2023 and has held it in 11 quarters since.
  • 76 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.